ESSA Pharma (EPIX)
(Real Time Quote from BATS)
$5.98 USD
-0.79 (-11.67%)
Updated Sep 18, 2024 03:51 PM ET
NA Value
NA Growth NA Momentum NA VGMESSA Pharma (EPIX) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$19.25 | $29.00 | $15.00 | 184.34% |
Price Target
Based on short-term price targets offered by four analysts, the average price target for ESSA Pharma comes to $19.25. The forecasts range from a low of $15.00 to a high of $29.00. The average price target represents an increase of 184.34% from the last closing price of $6.77.
Analyst Price Targets (4 )
Broker Rating
ESSA Pharma currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by three brokerage firms. The current ABR compares to an ABR of 1.00 a month ago based on four recommendations.
Of the three recommendations deriving the current ABR, three are Strong Buy, representing 100% of all recommendations. A month ago, Strong Buy represented 100%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 4 | 4 | 4 |
Buy | 0 | 0 | 0 | 0 | 0 |
Hold | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
9/16/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
9/11/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
8/6/2024 | Piper Sandler | Joseph M Catanzaro | Strong Buy | Strong Buy |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 1.00 |
ABR (Last week) | 1.00 |
# of Recs in ABR | 3 |
Average Target Price | $19.25 |
LT Growth Rate | NA |
Industry | Medical - Drugs |
Industry Rank by ABR | 74 of 253 |
Current Quarter EPS Est: | -0.21 |
EPIX FAQs
ESSA Pharma Inc. (EPIX) currently has an average brokerage recommendation (ABR) of 1.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by 3 brokerage firms.
The average price target for ESSA Pharma Inc. (EPIX) is $19.25. The current on short-term price targets is based on 4 reports.
The forecasts for ESSA Pharma Inc. (EPIX) range from a low of $15 to a high of $29. The average price target represents a increase of $184.34 from the last closing price of $6.77.
The current UPSIDE for ESSA Pharma Inc. (EPIX) is 184.34%
Based on short-term price targets offered by four analysts, the average price target for ESSA Pharma comes to $19.25. The forecasts range from a low of $15.00 to a high of $29.00. The average price target represents an increase of 184.34% from the last closing price of $6.77.